Skip to main content
. 2014 Apr 24;8(1):147–152. doi: 10.3892/etm.2014.1688

Table III.

FPG and HbA1c levels on completion of the trial.

Variable Insulin-glargine group (n=22) Standard-care group (n=20)
FPG (mmol/l) 5.79±0.83ab 7.17±1.77
HbA1c (%) 6.64±0.81 6.76±1.15
a

P<0.05, vs. standard-care group;

b

P<0.01, vs. baseline.

FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin.